Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience.
about
Contribution of glycosylated recombinant human granulocyte colony-stimulating factor (lenograstim) use in current cancer treatment: review of clinical data.Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT).Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection CentersLenograstim: a review of its use in chemotherapy-induced neutropenia, for acceleration of neutrophil recovery following haematopoietic stem cell transplantation and in peripheral blood stem cell mobilization.Novel agents and approaches for stem cell mobilization in normal donors and patients.Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?Hematopoietic stem cell donation.A review of the haematopoietic stem cell donation experience: is there room for improvement?The role of donor characteristics and post-granulocyte colony-stimulating factor white blood cell counts in predicting the adverse events and yields of stem cell mobilization.We have a specific duty to maximise the safety of related donorsVolunteer unrelated donor experience after administration of filgrastim and apheresis for the collection of haemopoietic stem cells: the Australian perspective.Clinical outcomes after peripheral blood stem cell donation by related donors: a Dutch single-center cohort study.Efficacy and safety of peripheral blood stem cell mobilization and collection: a single-center experience in 190 allogeneic donors.Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors.Granulocyte colony-stimulating factor off-target effect on nerve outgrowth promotes prostate cancer development.Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study.Mobilization of hematopoietic progenitor stem cells in allogeneic setting with lenograstim by subcutaneous injection, in daily or twice-daily dosing: a single-center prospective study with historical control.The impact of the age of HLA-identical siblings on mobilization and collection of PBSCs for allogeneic hematopoietic cell transplantation
P2860
Q33539387-25005999-F4B9-4B69-B5DC-733A297AD482Q34330585-AA025E2C-F913-46F6-928D-F4A93698F165Q36055063-C2287B69-3102-431A-91DC-84D915F82CC7Q37866758-044089C4-831B-4C21-9370-5507B9158918Q37923309-4F7D5AAD-960E-4DFF-A515-010F6819A71FQ37996560-A8BA90C9-B996-43EA-92CE-2191548B52EBQ38082689-B681304D-96CF-433A-B36F-A4795465B492Q38181958-EA3CBCC1-98C0-453B-B25A-070D3C468291Q40327354-2229826A-487B-445F-8B9D-9A066B7A286AQ42343632-8741885A-76A4-4AC4-AAC7-504D161483E3Q46661360-3D5540F8-CDF2-481E-AA44-01115042AA56Q47815315-13C02297-FF62-45A1-A3F0-4625BBCDF3B1Q47977709-2CB0B9D9-4003-47C5-937B-AFE169C412BBQ48192483-D27ACDB9-771F-4423-A4A3-26237CBD1B5FQ48687818-F92BD726-CD62-4439-B0BF-93786EB67737Q50506365-AB905C4C-8516-4D4B-8A9F-D8B54762742BQ53549083-0256DBA8-BBC8-454E-BB45-CBC0733466CCQ57515082-75A729C5-3B87-4FE2-A70B-8269D1B9CB42
P2860
Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Short and long-term safety of ...... s: a single centre experience.
@en
type
label
Short and long-term safety of ...... s: a single centre experience.
@en
prefLabel
Short and long-term safety of ...... s: a single centre experience.
@en
P2093
P2860
P356
P1476
Short and long-term safety of ...... rs: a single centre experience
@en
P2093
G Bresolin
P Iacopino
P2860
P2888
P304
P356
10.1038/BMT.2008.440
P407
P577
2009-02-02T00:00:00Z
P5875
P6179
1053441273